11/01/2024 3:30 PM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/07/2024 2:00 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/09/2024 1:03 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 5:57 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2024 6:00 AM | ESSA Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024 6:01 AM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 6:00 AM | ESSA Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
|
05/14/2024 6:01 AM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2024 4:17 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 9:35 AM | ESSA Pharma (Issuer) Glickman Richard M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 5:16 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/05/2024 2:02 PM | ESSA Pharma (Subject) Virsik Peter (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024 11:34 AM | ESSA Pharma (Issuer) Kantoff Philip W. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:35 AM | ESSA Pharma (Issuer) Martin John Alexander (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:36 AM | ESSA Pharma (Issuer) Merendino Lauren (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:38 AM | ESSA Pharma (Issuer) Requadt Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:39 AM | ESSA Pharma (Issuer) Sollis Gary (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:40 AM | ESSA Pharma (Issuer) Thorell Marella (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:41 AM | ESSA Pharma (Issuer) ZWEIFACH SANFORD S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:25 AM | Cesano Alessandra (Reporting) ESSA Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:27 AM | ESSA Pharma (Issuer) Parkinson David Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:30 AM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:31 AM | ESSA Pharma (Issuer) Wood David S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:32 AM | BERGER FRANKLIN M (Reporting) ESSA Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/28/2024 11:33 AM | ESSA Pharma (Issuer) Glickman Richard M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:18 PM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 5:50 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 6:05 AM | ESSA Pharma (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024 6:01 AM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 6:01 AM | ESSA Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/13/2024 5:04 AM | BB BIOTECH AG (Filed by) ESSA Pharma (Subject)
| Form SC 13G/A | |
02/08/2024 10:29 AM | ESSA Pharma (Subject) MORGAN STANLEY (Filed by)
| Form SC 13G | |
02/07/2024 10:29 AM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/06/2024 7:27 AM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 8:15 AM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/23/2024 3:09 PM | ESSA Pharma (Subject) Soleus Capital, LLC (Filed by)
| Form SC 13G/A | |
01/17/2024 7:57 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/16/2024 12:41 PM | ESSA Pharma (Issuer) Requadt Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2024 2:50 PM | ESSA Pharma (Subject) Gagnon Robert E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:06 PM | ESSA Pharma (Issuer) Virsik Peter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 8:57 PM | ESSA Pharma (Issuer) Parkinson David Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
We recommended Nvidia in 2016, now we’re recommending this… (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
12/12/2023 6:00 AM | ESSA Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/12/2023 6:01 AM | ESSA Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/24/2023 10:11 AM | ESSA Pharma (Issuer) Wood David S. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/22/2023 5:22 PM | BERGER FRANKLIN M (Reporting) ESSA Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2023 4:45 PM | BERGER FRANKLIN M (Reporting) ESSA Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 8:44 PM | ESSA Pharma (Filer)
| Form 424B5 | |